Cardior is a series b startup based in Germany. 1 investor tracked.
Cardior Therapeutics is a startup based in Germany. Cardior Therapeutics has been acquired. Brouky records 1 investor associated with the company.
Cardior Therapeutics is a clinical-stage biopharmaceutical company developing RNA-based therapeutics for cardiac diseases. Its lead program focuses on non-coding RNA to treat and potentially reverse heart failure.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.